What is the diagnosis for a patient with elevated N-terminal pro b-type natriuretic peptide (NT-proBNP) levels and a normal ejection fraction (EF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Heart Failure with Preserved Ejection Fraction (HFpEF)

A patient presenting with elevated NT-proBNP and normal ejection fraction most likely has heart failure with preserved ejection fraction (HFpEF), though you must systematically exclude other cardiac and non-cardiac causes of elevated natriuretic peptides before confirming this diagnosis. 1

Diagnostic Criteria for HFpEF

To establish HFpEF, the following conditions must be fulfilled according to the 2016 ESC Guidelines 1:

  • Presence of heart failure symptoms and/or signs - including dyspnea, orthopnea, bilateral edema, increased jugular venous pressure, rales, or S3 gallop 1
  • Preserved ejection fraction - defined as LVEF ≥50% (or 40-49% for HFmrEF) 1
  • Elevated natriuretic peptides - BNP >35 pg/mL and/or NT-proBNP >125 pg/mL in the ambulatory setting 1
  • Objective evidence of cardiac structural/functional abnormalities - demonstrated on echocardiography, such as left atrial enlargement, left ventricular hypertrophy, elevated E/e' ratio >9, or elevated pulmonary artery systolic pressure >35 mmHg 1

Critical Differential Diagnoses to Exclude

Before confirming HFpEF, you must systematically rule out other causes of elevated NT-proBNP with normal EF 2, 3:

Cardiac Causes

  • Atrial fibrillation - causes elevated BNP independent of ventricular function, with levels 2.59 times higher than sinus rhythm 2, 4, 5
  • Acute coronary syndrome - BNP rises significantly during myocardial infarction even without clinical heart failure 2, 3
  • Valvular disease - particularly mitral regurgitation, which elevates BNP and carries increased mortality risk 2, 3

Pulmonary Causes

  • Pulmonary embolism - significantly elevates BNP, especially in massive PE 2, 3
  • Chronic obstructive pulmonary disease with cor pulmonale - substantially elevates BNP, though COPD without cor pulmonale shows minimal elevation 2, 3
  • Pulmonary hypertension - elevates natriuretic peptides related to right ventricular dysfunction 1, 3

Renal Dysfunction

  • Renal failure - leads to elevated BNP due to decreased clearance, requiring adjusted thresholds for interpretation 1, 2, 3

Systemic Conditions

  • Sepsis - can contribute to elevated levels, especially with cardiac involvement 1, 2

Diagnostic Algorithm

Step 1: Confirm HF symptoms/signs are present 1

  • Look specifically for: orthopnea, paroxysmal nocturnal dyspnea, jugular venous distension, hepatojugular reflux, bilateral lower extremity edema, pulmonary rales, S3 gallop, tachycardia >120 bpm 1

Step 2: Verify elevated natriuretic peptides meet diagnostic thresholds 1

  • Ambulatory: NT-proBNP >125 pg/mL or BNP >35 pg/mL 1
  • Hospitalized: NT-proBNP >300 pg/mL or BNP >100 pg/mL 1

Step 3: Obtain echocardiography to confirm 1:

  • LVEF ≥50% 1
  • Evidence of diastolic dysfunction: E/e' ratio >9, left atrial enlargement, left ventricular hypertrophy 1
  • Elevated pulmonary artery systolic pressure >35 mmHg 1
  • Exclude significant valvular disease 1

Step 4: Consider H2FPEF score for diagnostic certainty 1

  • Integrates: obesity, atrial fibrillation, age >60 years, ≥2 antihypertensive medications, E/e' >9, PA systolic pressure >35 mmHg 1
  • Score <2 = low likelihood of HFpEF; Score ≥6 = high likelihood 1
  • Score 2-5 = requires exercise echocardiogram or cardiac catheterization to confirm diagnosis 1

Step 5: If diagnosis remains uncertain, perform stress testing 1

  • Exercise echocardiography or invasive measurement of elevated LV filling pressure during exercise may be needed to confirm HFpEF 1

Important Clinical Caveats

Factors That Lower NT-proBNP in HFpEF

  • Obesity - paradoxically results in lower BNP values for any given cardiac condition, possibly related to increased clearance 1, 2, 6, 7
  • Chronically treated patients - especially those younger than 75 years may have normal-range BNP despite true HFpEF 7
  • Reduced myocardial wall stress - HFpEF patients have small LV cavity and thick walls, producing lower stimulus for BNP production compared to HFrEF even with high diastolic pressures 1, 7

Factors That Raise NT-proBNP Without HFpEF

  • Advanced age - normal ranges increase significantly in patients >60 years 2, 3
  • Female sex - women typically have higher normal values than men 1
  • Atrial fibrillation - raises levels independent of ventricular function 2, 4, 5

Common Diagnostic Pitfalls

  • Do not rely on BNP alone - natriuretic peptides have high negative predictive value (0.94-0.98) for ruling out HF but lower positive predictive value (0.44-0.57 in non-acute setting) for confirming diagnosis 1
  • Always integrate with clinical assessment and echocardiography - BNP should never be used in isolation to establish the diagnosis 1, 2, 3
  • Recognize the "grey zone" - BNP 100-400 pg/mL or NT-proBNP 300-900 pg/mL requires comprehensive clinical correlation 8
  • Adjust thresholds for obesity - consider lowering threshold values by 20-30% for patients with BMI ≥30 kg/m² 3

Prognostic Implications

Once HFpEF is confirmed, elevated NT-proBNP carries significant prognostic value 4, 9:

  • Higher NT-proBNP levels are associated with worse outcomes including increased mortality, heart failure hospitalization, atrial fibrillation, and stroke 3, 8
  • For each 100 pg/mL increase in BNP, relative risk of death increases by 35% over 1.5-3 years 2, 8
  • Baseline characteristics most strongly associated with higher NT-proBNP in HFpEF include atrial fibrillation, NYHA IV symptoms, lower estimated glomerular filtration rate, and recent heart failure hospitalization 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Heart Failure Causes of Elevated BNP

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Pro-Brain Natriuretic Peptide (proBNP) Levels: Causes and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2016

Guideline

BNP Levels and Heart Failure Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.